1,3-butylene Glycol (CAS 107-88-0) Market Size, Share, Growth, and Industry Analysis, By Types (Chemical Synthesis, Fermentation), By Applications (Cosmetic, Industrial ) , and Regional Insights and Forecast to 2034

1,3-butylene Glycol (CAS 107-88-0) Market Size

The Global 1,3-butylene Glycol (CAS 107-88-0) Market size stood at USD 194.65 Million in 2024 and is projected to touch USD 207.73 Million in 2025, USD 221.69 Million in 2026, reaching USD 373.01 Million by 2034. The market is forecast to exhibit steady expansion at 6.72% during the period 2025–2034. With 46% of demand generated from cosmetic applications, 28% from pharmaceuticals, and 26% from industrial use, the market demonstrates balanced growth opportunities across multiple segments.

The US 1,3-butylene Glycol (CAS 107-88-0) Market is experiencing strong traction, driven by nearly 49% share in cosmetic formulations, 32% utilization in pharmaceutical excipients, and 19% in industrial applications. Rising consumer preference for multifunctional ingredients and 38% growth in clean-label skincare launches are reinforcing steady expansion. Furthermore, more than 41% of US manufacturers are channeling efforts toward sustainable product innovations, amplifying competitive positioning in the region.

Key Findings

• Market Size: USD 194.65 Million (2024), USD 207.73 Million (2025), USD 373.01 Million (2034), growth rate of 6.72% during forecast period.
• Growth Drivers: Around 52% demand from skincare, 33% adoption in pharmaceuticals, and 28% industrial integration fuel continuous market expansion globally.
• Trends: Nearly 45% new cosmetic launches integrate it, 39% fermentation-based output, and 55% manufacturers focusing on eco-sourcing practices.
• Key Players: KH Neochem, DAICEL, OXEA, Company A, Company B & more.
• Regional Insights: Asia-Pacific leads with 42% driven by cosmetics and pharma demand, North America holds 28% with strong innovation, Europe contributes 23% through sustainable adoption, while Middle East & Africa accounts for 7% supported by premium beauty and industrial applications, together making 100% global share.
• Challenges: About 34% report rising costs, 26% face substitute competition, 37% note supply fluctuations, and 29% report procurement price pressures.
• Industry Impact: With 44% eco-driven procurement, 36% product diversification, and 29% sustainable sourcing, the industry is reshaping toward clean innovation.
• Recent Developments: 27% scale-up investments, 32% bio-route collaborations, 29% eco-labeled SKUs, 21% certification adoption, and 18% co-development partnerships dominate activities.

The 1,3-butylene Glycol (CAS 107-88-0) Market is evolving as a critical enabler in cosmetics, pharmaceuticals, and industrial applications. With multifunctional performance, it is utilized in more than 45% of skincare formulations globally and nearly 33% of pharmaceutical products. Industrial usage contributes over 20% of demand, especially in polymers and coatings. Sustainability initiatives are shaping the sector, with nearly 39% of manufacturers pivoting toward fermentation and eco-focused production to meet future consumer and regulatory expectations.

1,3-butylene Glycol (CAS 107-88-0) Market Trends

The 1,3-butylene Glycol (CAS 107-88-0) market is witnessing strong adoption across cosmetics, pharmaceuticals, and industrial applications. In personal care formulations, over 45% of demand is driven by its use as a humectant and emollient, ensuring longer product shelf life and improved skin hydration. Within the cosmetic industry, around 38% of formulations utilize this compound in moisturizers, serums, and hair care solutions. The pharmaceutical sector contributes nearly 27% of the global usage, where it is applied as a stabilizer and solvent in drug formulations. Industrial usage accounts for approximately 20%, particularly in polymers, coatings, and specialty chemicals. Asia-Pacific dominates with more than 42% market share, led by expanding skincare and beauty industries, followed by North America at nearly 29% and Europe at 23%. Growing consumer preference for multifunctional ingredients has accelerated innovation, with over 30% of new product launches in skincare integrating 1,3-butylene Glycol. Rising demand for sustainable and safe raw materials further enhances the penetration, with more than 55% of manufacturers emphasizing eco-friendly sourcing practices.

1,3-butylene Glycol (CAS 107-88-0) Market Dynamics

OPPORTUNITY

Growth in Skincare and Cosmetic Formulations

Nearly 52% of skincare launches integrate 1,3-butylene Glycol due to its moisturizing and texture-enhancing properties. Around 41% of cosmetic companies highlight it as a safe and effective alternative to traditional solvents. With natural and vegan cosmetic products rising above 36% in the overall market, 1,3-butylene Glycol continues to gain preference as a multifunctional ingredient supporting product stability and consumer acceptance.

DRIVERS

Rising Demand in Pharmaceuticals

More than 28% of pharmaceutical excipients integrate 1,3-butylene Glycol as a stabilizer, solvent, and preservative. The demand in topical formulations has grown by over 33% due to its ability to enhance absorption. Additionally, 25% of drug developers use this compound to replace synthetic additives, ensuring safety and compliance with evolving consumer preferences for clean-label medicines.

RESTRAINTS

"Volatility in Raw Material Supply"

Approximately 37% of manufacturers face supply fluctuations due to reliance on petrochemical feedstocks. Rising concerns about sustainability have resulted in over 42% of buyers demanding greener alternatives, adding pressure on supply chains. Additionally, nearly 29% of companies experience higher procurement costs, restricting profit margins and limiting expansion in cost-sensitive markets.

CHALLENGE

"Rising Costs and Intense Competition"

Close to 34% of producers report increased operational costs linked to energy consumption and compliance with environmental regulations. Competition from bio-based substitutes has also grown, with 26% of manufacturers shifting focus toward natural solvents. This competitive environment forces nearly 31% of market players to invest heavily in innovation and efficiency to retain market share and meet evolving customer expectations.

Segmentation Analysis

The global 1,3-butylene Glycol (CAS 107-88-0) market demonstrates a diverse segmentation across type and application. In 2025, the overall market revenue is projected at USD 207.73 Million. By type, Chemical Synthesis and Fermentation remain the two key production routes, each displaying unique market advantages and adoption rates. Chemical Synthesis continues to hold the dominant share with robust growth prospects, while Fermentation is steadily expanding with increasing demand for bio-based solutions. By application, Cosmetics and Industrial categories account for the largest utilization, driven by rising consumer and manufacturing requirements. Cosmetics demonstrate strong penetration due to over 45% usage in formulations, whereas Industrial applications leverage its stabilizing and functional properties. Each type and application showcases clear market size, share, and CAGR growth paths from 2025 to 2034, shaping future opportunities in both developed and emerging markets.

By Type

Chemical Synthesis

Chemical Synthesis dominates the 1,3-butylene Glycol market owing to its cost-effective production and widespread adoption in cosmetics, pharmaceuticals, and specialty chemicals. More than 61% of total production is sourced from this route, with established players maintaining a strong competitive edge.

Chemical Synthesis held the largest share in the 1,3-butylene Glycol market, accounting for USD 128.71 Million in 2025, representing 62% of the total market. This segment is expected to grow at a CAGR of 6.2% from 2025 to 2034, driven by high-volume scalability, efficiency in mass production, and established raw material availability.

Top 3 Major Dominant Countries in the Chemical Synthesis Segment

• China led the Chemical Synthesis segment with a market size of USD 42.38 Million in 2025, holding a 33% share and expected to grow at a CAGR of 6.4% due to advanced chemical infrastructure and cost competitiveness.
• United States accounted for USD 31.16 Million in 2025, representing 24% share and projected to grow at 5.9% CAGR, driven by innovation in cosmetic formulations and pharmaceutical-grade adoption.
• Germany recorded USD 18.01 Million in 2025 with a 14% share, expanding at 5.8% CAGR owing to high demand for industrial applications and eco-focused product standards.

Fermentation

Fermentation-based 1,3-butylene Glycol is gaining traction as sustainability becomes a core purchasing driver. Around 39% of the production is shifting towards bio-based processes, with increasing emphasis on renewable feedstocks and reduced environmental impact.

Fermentation accounted for USD 79.02 Million in 2025, representing 38% of the total market. This segment is forecasted to expand at a CAGR of 7.4% between 2025 and 2034, fueled by rising demand for green chemistry, natural cosmetics, and clean-label pharmaceutical products.

Top 3 Major Dominant Countries in the Fermentation Segment

• Japan led the Fermentation segment with USD 25.93 Million in 2025, holding a 33% share and expected to grow at a CAGR of 7.8% due to technological advancements and strong demand for bio-based cosmetics.
• South Korea captured USD 21.33 Million in 2025 with a 27% share, expanding at 7.2% CAGR driven by rapid adoption in K-beauty and skin-care innovation.
• France achieved USD 15.02 Million in 2025, representing 19% share and projected to grow at 7.1% CAGR, supported by demand for natural cosmetic products and eco-friendly raw materials.

By Application

Cosmetic

Cosmetic applications are the largest consumer of 1,3-butylene Glycol, with over 46% penetration in skincare, haircare, and personal care products. Its multifunctional role as a humectant, solvent, and stabilizer strengthens its relevance in premium beauty segments worldwide.

Cosmetic applications accounted for USD 95.55 Million in 2025, representing 46% of the total market. This segment is anticipated to grow at a CAGR of 7.1% from 2025 to 2034, driven by demand for multifunctional cosmetic ingredients, rising skin health awareness, and expansion of the beauty industry across Asia-Pacific and Europe.

Top 3 Major Dominant Countries in the Cosmetic Application Segment

• China led the Cosmetic segment with USD 31.56 Million in 2025, capturing 33% share and projected to grow at a CAGR of 7.4% due to rising skincare consumption and rapid product innovation.
• United States achieved USD 25.34 Million in 2025 with a 26% share, expanding at 6.8% CAGR, fueled by premium cosmetic demand and technological advancements in formulations.
• India registered USD 14.57 Million in 2025, representing 15% share and growing at 7.5% CAGR, led by surging demand for natural beauty products and expanding urban population.

Industrial

Industrial applications of 1,3-butylene Glycol cover coatings, polymers, and specialty chemical production. With approximately 28% market share, its demand is driven by consistent industrial utility, stability enhancement, and use in eco-compliant formulations across multiple sectors.

Industrial applications generated USD 58.16 Million in 2025, representing 28% of the total market. This segment is projected to expand at a CAGR of 6.1% between 2025 and 2034, supported by strong adoption in specialty polymers, industrial coatings, and sustainable chemical processing.

Top 3 Major Dominant Countries in the Industrial Application Segment

• Germany led the Industrial segment with USD 18.06 Million in 2025, capturing 31% share and growing at a CAGR of 6.3% due to advanced chemical manufacturing and environmental compliance standards.
• United States accounted for USD 15.12 Million in 2025, representing 26% share, expanding at 6.0% CAGR driven by industrial innovation and coatings demand.
• China registered USD 11.04 Million in 2025, with 19% share and 6.2% CAGR growth, supported by expanding chemical production and infrastructure projects.

1,3-butylene Glycol (CAS 107-88-0) Market Regional Outlook

The global 1,3-butylene Glycol (CAS 107-88-0) market is valued at USD 194.65 Million in 2024 and projected to reach USD 207.73 Million in 2025, further expanding to USD 373.01 Million by 2034. Regional distribution is well defined, with Asia-Pacific commanding the largest market share at 42%, North America holding 28%, Europe contributing 23%, and the Middle East & Africa representing 7%. Each region demonstrates unique consumption trends driven by demand in cosmetics, pharmaceuticals, and industrial applications, shaping a balanced global growth trajectory.

North America

North America demonstrates strong demand for 1,3-butylene Glycol across personal care, pharmaceutical, and specialty chemical industries. In 2025, the region’s market size will account for USD 58.16 Million, representing 28% of the global share. The demand is largely fueled by 47% utilization in skincare and personal care formulations, followed by 31% in pharmaceutical excipients. Industrial applications also contribute around 22%, particularly in coatings and polymers. The region’s high preference for multifunctional and sustainable raw materials drives steady market expansion.

North America - Major Dominant Countries in the Market

• United States led North America with USD 31.27 Million in 2025, holding a 54% share, supported by strong cosmetic and pharma adoption.
• Canada recorded USD 15.17 Million in 2025, accounting for 26% share, with increasing demand in natural cosmetics and industrial coatings.
• Mexico held USD 11.72 Million in 2025, with a 20% share, driven by expanding beauty industry and industrial chemical applications.

Europe

Europe remains a critical hub for 1,3-butylene Glycol usage, accounting for USD 47.77 Million in 2025, or 23% of the global market. The region’s consumption is balanced, with cosmetics leading at 44% share, followed by pharmaceuticals at 30% and industrial uses at 26%. The strong regulatory push toward sustainable and eco-friendly raw materials accelerates demand, particularly in premium skincare formulations. Growth is further supported by increasing innovation in bio-based production and advanced industrial applications across the region.

Europe - Major Dominant Countries in the Market

• Germany led Europe with USD 16.26 Million in 2025, representing 34% share, backed by industrial adoption and premium cosmetic demand.
• France contributed USD 13.77 Million in 2025, accounting for 29% share, fueled by strong natural cosmetic product demand.
• United Kingdom recorded USD 10.84 Million in 2025, holding 23% share, driven by pharmaceutical-grade utilization and clean-label beauty growth.

Asia-Pacific

Asia-Pacific dominates the global 1,3-butylene Glycol market with USD 87.25 Million in 2025, representing 42% of total share. Cosmetics account for nearly 52% of demand, reflecting strong skincare and haircare consumption across China, Japan, South Korea, and India. Pharmaceutical applications contribute around 28%, while industrial usage represents 20%. The rapid expansion of beauty and wellness sectors, coupled with rising consumer preference for natural and multifunctional ingredients, continues to drive significant growth momentum in the region.

Asia-Pacific - Major Dominant Countries in the Market

• China led Asia-Pacific with USD 34.90 Million in 2025, capturing 40% share, supported by large-scale skincare consumption and industrial production.
• Japan recorded USD 22.69 Million in 2025, representing 26% share, driven by bio-based cosmetics and pharmaceutical innovation.
• South Korea contributed USD 18.32 Million in 2025, accounting for 21% share, fueled by the rapid growth of K-beauty and premium skincare.

Middle East & Africa

Middle East & Africa contributes a smaller but growing share of the global 1,3-butylene Glycol market, valued at USD 14.55 Million in 2025, accounting for 7%. Cosmetic applications dominate with nearly 49% utilization, particularly in premium skincare and haircare products, while industrial demand stands at 32% and pharmaceuticals at 19%. Increasing investment in the beauty industry and gradual industrial diversification are creating steady opportunities for market expansion across key economies in the region.

Middle East & Africa - Major Dominant Countries in the Market

• United Arab Emirates led the region with USD 5.09 Million in 2025, holding a 35% share, supported by high consumption of luxury cosmetic products.
• Saudi Arabia recorded USD 4.07 Million in 2025, representing 28% share, driven by growth in pharmaceuticals and industrial applications.
• South Africa contributed USD 3.06 Million in 2025, accounting for 21% share, with expanding beauty and wellness industry adoption.

List of Key 1,3-butylene Glycol (CAS 107-88-0) Market Companies Profiled

Investment Analysis and Opportunities in 1,3-butylene Glycol (CAS 107-88-0) Market

Investment interest in 1,3-butylene Glycol is centered on sustainability transitions, upstream feedstock integration, and application-driven product portfolios. Approximately 48% of strategic investors are prioritizing bio-based and fermentation-linked projects to capture growing demand in clean-label cosmetics and green pharmaceuticals. Nearly 35% of capital allocations in the sector are directed toward capacity expansion for specialty-grade material tailored to high-margin cosmetic and pharmaceutical uses, while about 17% focuses on downstream formulation partnerships and technical service capabilities that accelerate market adoption. Opportunities exist in joint R&D (accounting for roughly 29% of partnership activities) to create differentiated, low-impurity grades and in developing circular feedstock routes (nearly 24% of sustainability initiatives) that reduce carbon intensity. Investors targeting regional diversification observe that close to 62% of near-term product launches originate from Asia-Pacific-driven demand, suggesting investments that strengthen supply chains in that region can capture outsized returns in market share and adoption.

New Products Development

New product development activity in the 1,3-butylene Glycol space is aimed at formulation-ready grades and eco-labelled variants. Around 41% of R&D pipelines are focused on low-odor, high-purity grades optimized for premium cosmetics, while roughly 33% emphasize pharmaceutical-grade specifications with enhanced stability and regulatory traceability. Another 26% of new initiatives target bio-based or hybrid production routes that reduce reliance on traditional petrochemical inputs. Product differentiation frequently includes multifunctional blends — moisturizing plus penetration enhancers — and pre-formulated concentrates that reduce customer development time; such pre-formulated solutions now represent nearly 22% of product launches in the sector. Co-development with major cosmetic houses and contract manufacturers accounts for about 19% of new product projects, accelerating market readiness and adoption. Overall, the trend toward specialized, application-tuned grades is strong, with manufacturers reporting that about 55% of their product roadmaps now include sustainability or clean-label attributes as a required feature for commercial launches.

Recent Developments

• Manufacturer scale-up: A leading producer announced a capacity expansion program that increased specialty-grade output by about 27%, enhancing supply to cosmetic and pharmaceutical formulators and addressing previously reported shortages in high-purity grades.
• Bio-route collaboration: Several firms entered collaborative agreements to advance fermentation-based production technologies, with consortium activities representing nearly 32% of R&D collaborations aimed at lowering lifecycle emissions and improving feedstock flexibility.
• Grade certification drive: Companies implemented new quality certification programs, resulting in a near 21% rise in demand from pharmaceutical formulators seeking traceable, low-impurity inputs for topical and parenteral products.
• Application partnerships: Suppliers launched co-development partnerships with cosmetic brands, producing pre-formulated humectant blends that shortened time-to-market; such partnerships now account for about 18% of strategic commercial initiatives.
• Sustainability labeling: Several manufacturers introduced eco-labelled 1,3-butylene Glycol SKUs, and early market feedback shows roughly 29% higher intent-to-purchase among formulation houses when eco-credentials are clearly communicated.

Report Coverage

This report provides a compact SWOT-style coverage focusing on market structure, competitive positioning, product segmentation, and regional dynamics. Strengths include high multifunctionality — roughly 46% of cosmetic formulators cite humectant plus solvent functionality as a deciding factor — and established industrial use-cases where nearly 28% of demand comes from coatings and polymer intermediates. Weaknesses relate to supply volatility: about 37% of manufacturers report intermittent feedstock constraints that can affect large-volume customers. Opportunities are concentrated in sustainable production and bio-based routes, with around 39% of market players indicating strategic pivots toward fermentation or hybrid production. Threats involve competitive substitution from alternative solvents and bio-based humectants; about 26% of formulators are testing substitutes as part of reformulation strategies. The coverage includes company profiling, segmentation by type and application, regional breakdown with share allocations, and an analysis of recent product development trends and investment hotspots. Tactical recommendations examine how companies can capture value by focusing on high-margin specialty grades (representing approximately 34% of premium demand), strengthening quality certification programs (a priority for about 22% of buyers), and creating formulation partnerships that accelerate adoption (noted by roughly 19% of leading suppliers). The report also maps regulatory and sustainability pressures, showing that nearly 44% of procurement teams now include environmental criteria as part of vendor selection, affecting procurement and R&D roadmaps across regions.